Medscape - A significant reduction of the incidence of cardiovascular death or worsening heart failure with dapagliflozin became apparent in DAPA-HF within 28 days after patients...
Medscape - A significant reduction of the incidence of cardiovascular death or worsening heart failure with dapagliflozin became apparent in DAPA-HF within 28 days after patients...
Dapagliflozin Quickly Reduces Heart Failure Events https://t.co/nkaf7H1B5f via @medscape @mvaduganathan @scottdsolomon @SJGreene_md @NMHheartdoc @JAMACardio